Interim Data Demonstrate Meaningful Reduction of All-Cause Mortality with AMDS
ATLANTA, Oct. 5, 2023 /PRNewswire/ Artivion, Inc. , a leading cardiac and vascular surgery company focused on aortic.
/PRNewswire/ Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, today presented interim results from the.